Negócios · 09/12/19971 min de leitura
Establishment of Prescription Drug User Fee Rates for Fiscal Year 1998
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing the rates for prescription drug user fees for Fiscal Year (FY) 1998. The Prescription Drug User Fee Act of 1992 (the PDUFA), as amended by the Food and Drug Administration Modernization Act of 1997 (the FDAMA), authorizes FDA to collect user fees for certain applications for approval of drug and biological products, on establishments where the products are made, and on such products. Fees for applications for FY 1998 were set by the FDAMA, subject to adjustment for inflation. Total application fee revenues fluctuate with FDA application review workload. Fees for establishments and products are based on the revenues to be derived from applications.